Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

W. Akkerman, Onno; Aleksa, Alena; C. Alffenaar, Jan‐Willem; Hassan Al-Marzouqi, Nada; Arias-Guillén, Miguel; Belilovski, Evgeny; Bernal, Enrique; J. Boeree, Martin; Se, Borisov; Bruchfeld, Judith; Cadiñanos, Julen; Cai, Qingshan; A. Caminero, José; Joaquín Cebrián Gallardo, José; Centis, Rosella; Ruffo Codecasa, Luigi; D’Ambrosio, Lia; Pretti Dalcolmo, Margareth; Danila, Edvardas; Dara, Masoud; Davidavičienė, Edita; Davies Forsman, Lina; De Los Rios Jefe, Jorge; T. Denholm, Justin; Duarte, Raquel; Eltaeb Elamin, Seifeldin; Ferrarese, Maurizio; Av, Filippov; Ganatra, Shashank; María García‐Bores, Ana; García-García, José-María; Gayoso, Regina; María Giraldo Montoya, Ángela; Gomez Rosso, R.; Gualano, Gina; Hoefsloot, Wouter; Ilievska-Poposka, Biljana; Jonsson, Jerker; Khimova, Elena; Kukša, Līga; Kunst, Heinke; Laniado-Laborı́n, Rafael; Li, Yang; Magis-Escurra, Cécile; Manfrin, Vinicio; Manga, Selene; Marchese, Valentina; Martínez Robles, Elena; Maryandyshev, Andrei; Matteelli, Alberto; Battista Migliori, Giovanni; Mullerpattan, Jai; Muñóz-Torrico, Marcela; Mustafa Hamdan, Hamdan; Nieto Marcos, Magnolia; Mohamad Noordin, Noorliza; Palmero, Domingo; Palmieri, Fabrizio; Payen, Marie‐Christine; Piubello, Alberto; Pontali, Emanuele; Pontarelli, Agostina; Quirós, Sarái; Rendón, Adrián; Skrahina, Alena; Šmite, Agnese; Solovič, Ivan; Sotgiu, Giovanni; Bassirou Souleymane, Mahamadou; Spanevello, Antonio; Stošić, Maja; Tadolini, Marina; Tiberi, Simon; Udwadia, Zarir; van den Boom, Martin; Vescovo, Marisa; Viggiani, Pietro; Visca, Dina; Zhurkin, Dmitry; Zignol, Matteo

doi:10.1016/j.ijid.2019.03.036

Public

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

Published in International Journal of Infectious Diseases • Apr 3, 2019

Authors:

Onno W. Akkerman

Alena Aleksa

Jan‐Willem C. Alffenaar

Abstract

The World Health Organization launched a global initiative, known as aDSM (active TB drug safety monitoring and management) to better describe the safety profile of new treatment regimens for drug-resistant tuberculosis (TB) in real-world settings. However, comprehensive surveillance is difficult to...

Subject

Bedaquiline

Medicine

Tuberculosis

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!